Report : Asia Pacific Dermal Fillers Market Forecast to 2031 - Regional Analysis - by Product (Biodegradable and Nonbiodegradable), Material (Calcium Hydroxylapatite, Hyaluronic Acid, Collagen, Poly-L-Lactic Acid, Polmethylmethacrylate (PMMA), Fat Fillers, and Others), Application (Facial Line Correction Treatment, Lip Enhancement, Face Lift, Scar Treatment, and Others), and End User (Multispecialty Hospitals, Dermatology Clinics, Ambulatory Surgical Centers, and Others)
At 9.4% CAGR, Asia Pacific Dermal Fillers Market is Speculated to be Worth US$ 1,757.83 Million by 2031, says Business Market Insights
According to Business Market Insights’ research, the Asia Pacific dermal fillers market was valued at US$ 854.98 million in 2023 and is expected to reach US$ 1,757.83 million by 2031, registering a CAGR of 9.4% from 2023 to 2031. Growing medical tourism for cosmetic procedures and increasing disposable incomes and expanding middle-class population are among the critical factors attributed to drive the Asia Pacific dermal fillers market growth.
Countries such as India, South Korea, Thailand, Saudi Arabia, Malaysia, Mexico, and the UAE have emerged as the world's best medical tourism destinations. These countries are at the forefront of offering aesthetic services such as nose jobs, facelifts, lip jobs, liposuctions, and hair transplantation. According to the South Korean Ministry of Health and Welfare (MOHW), South Korea recorded a 70% increase in medical tourists from 2021 to 2022, with the number reaching ~248,000 in 2022 from 146,000 in 2021. As per the Society of Aesthetic Plastic Surgery, South Korea is among the countries performing the greatest number of plastic surgeries annually. Estimates by South Korean MOHW suggest that the country aims to attract ~700,000 international patients by 2027 to become a medical tourism hub in Asia. Therefore, with flourishing medical tourism, the demand for aesthetic procedures will likely surge in developing countries, bolstering the adoption of dermal fillers in the coming years. Low-cost procedures that do not compromise the treatment quality can primarily result in the growth of medical tourism and generate lucrative opportunities for the dermal fillers market in the coming years.
On the contrary, high cost of dermal filler procedures hampers the growth of Asia Pacific dermal fillers market.
Based on product, the Asia Pacific Dermal Fillers Market is bifurcated biodegradable and nonbiodegradable. The biodegradable segment held 92.8% market share in 2023, amassing US$ 793.24 million. It is projected to garner US$ 1,644.79 million by 2031 to register 9.5% CAGR during 2023–2031.
In terms of material, the Asia Pacific Dermal Fillers Market is categorized calcium hydroxylapatite, hyaluronic acid, collagen, poly-l-lactic acid, polmethylmethacrylate (PMMA), fat fillers, and others. The hyaluronic acid segment held 60.1% share of Asia Pacific dermal fillers market in 2023, amassing US$ 513.67 million. It is anticipated to garner US$ 1,097.04 million by 2031 to expand at 9.9% CAGR during 2023–2031.
By application, the Asia Pacific Dermal Fillers Market is segmented into facial line correction treatment, lip enhancement, face lift, scar treatment, and others. The lip enhancement segment held 37.0% market share in 2023, amassing US$ 316.28 million. It is projected to garner US$ 673.15 million by 2031 to register 9.9% CAGR during 2023–2031.
By end user, the Asia Pacific Dermal Fillers Market is segmented into multispecialty hospitals, dermatology clinics, ambulatory surgical centers, and others. The dermatology clinics segment held 45.1% market share in 2023, amassing US$ 385.63 million. It is projected to garner US$ 815.52 million by 2031 to register 9.8% CAGR during 2023–2031.
By country, the Asia Pacific Dermal Fillers Market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. Our regional analysis states that China captured 33.7% share of Asia Pacific dermal fillers market in 2023. It was assessed at US$ 287.96 million in 2023 and is likely to hit US$ 599.72 million by 2031, registering a CAGR of 9.6% during 2023–2031.
Key players operating in the Asia Pacific dermal fillers market are AbbVie Inc; BIOPLUS CO., LTD.; BIOXIS pharmaceuticals; Galderma SA; Merz Pharma GmbH & Co KGaA; Prollenium Medical Technologies; Sinclair Pharma Ltd; Suneva Medical; and TEOXANE LABORATORIES; among others.